Follow-The-Filings

Security

ALNY

Alnylam Pharmaceuticals Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

15 owners 1 new 2 exits max 0.4% (Marshall Wace - Marshall ...)

grid → activity → earnings →
owners 15
max % 0.4%
tracked value $8.4B
qoq N 1 A 6 R 6 E 2

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.4% Add +0.16 pp 1,099,318 $364M hist
Dodge & Cox 2026 Q1 0.4% Reduce -0.07 pp 1,929,253 $638M hist
Two Sigma Investments, LP 2025 Q4 stale 0.4% Exit -0.35 pp 616,120 $245M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.2% Add +0.11 pp 1,059,062 $350M hist
Ray Dalio - Bridgewater Associates, LP 2026 Q1 0.2% Add +0.03 pp 106,592 $35M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.1% Reduce -0.06 pp 913,104 $298M hist
Norges Bank 2025 Q4 stale 0.1% Exit -0.10 pp 2,252,775 $896M hist
Vanguard Group Inc. 2025 Q4 stale 0.1% Reduce -0.01 pp 13,553,932 $5.4B hist
Israel Englander - Millennium Management LLC 2026 Q1 0.1% Add +0.05 pp 447,887 $148M hist
Natixis Advisors, LLC 2026 Q1 0.0% Add +0.01 pp 78,016 $26M hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.0% Add -0.01 pp 43,710 $14M hist
Murray Stahl - Horizon Kinetics Asset Management LLC 2026 Q1 0.0% Reduce 0.00 pp 2,272 $752 hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 23,415 $8M hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% New 0.0% 6,045 $2M hist
Ancora Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 11 $4 hist
Ron Baron - Bamco Inc. /NY/ (Baron Capital) exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 3,500 $1M hist
Dmitry Balyasny - Balyasny Asset Management L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 3,026 $1M hist

15 current · 2 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 25 shown

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q 10-Q Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
8-K 5.02,5.07 Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q 10-Q Filing Doc
4 PRIMARY DOCUMENT Filing Doc
DEFA14A DEFA14A Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
4 PRIMARY DOCUMENT Filing Doc
8-K 5.02 Filing Doc

Updated 13 minutes ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.83B $2.25B $3.71B
Gross profit * $1.56B $1.94B $3.04B
Gross margin * 85.3% 86.4% 81.8%
Net income -$440.24M -$278.16M -$18.25M
Net margin * -24.1% -12.4% -0.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.98B $3.3B $4.05B
Total non-current assets * $847.18M $944.7M $915.67M
Total assets $3.83B $4.24B $4.97B
Total current liabilities $967.79M $1.19B $1.47B
Total non-current liabilities * $3.08B $2.99B $2.71B
Total equity -$220.64M $67.09M $789.18M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $104.16M -$8.31M $524.08M
Cash from investing -$336.35M -$116.84M $436.33M
Cash from financing $172.13M $294.16M -$305.19M
Net change in cash -$53.67M $153.77M $690.16M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders